UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000010475
Receipt No. R000012241
Official scientific title of the study Determination of the effect of topical glucorticosteroid on the barrier function of human nasal mucosa
Date of disclosure of the study information 2013/04/12
Last modified on 2017/04/15 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Determination of the effect of topical glucorticosteroid on the barrier function of human nasal mucosa
Title of the study (Brief title) Effects of topical glucorticosteroid on the human nasal barrier
Region
Japan

Condition
Condition allergic rhinitis
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To detect the effect of topical glucocorticoid, pre and post nasal provocation on nasal mucosal barrier
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes nasal transepithelial water loss, nasal potential differences
Key secondary outcomes clinical symptoms

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as a block.
Blocking YES
Concealment No need to know

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 fluticasone furoate
Interventions/Control_2 fluticasone furoate placebo
Interventions/Control_3 mometasone furoate
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Japanese cedar poliinosis
Key exclusion criteria allergic rhinitis with active inflammation
Target sample size 1

Research contact person
Name of lead principal investigator masato miwa
Organization Juntendo Universiry
Division name Otorhinolaryngology
Address 3-1-3 Hongo Bunkyo Tokyo
TEL 03-5802-1229
Email mmiwa@juntendo.ac.jp

Public contact
Name of contact person masato miwa
Organization Juntendo Universiry
Division name Otorhinolaryngology
Address 3-1-3 Hongo Bunkyo Tokyo
TEL 03-5802-1229
Homepage URL
Email mmiwa@juntendo.ac.jp

Sponsor
Institute Juntendo University
Institute
Department

Funding Source
Organization Juntendo University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 順天堂医院(東京都)

Other administrative information
Date of disclosure of the study information
2013 Year 04 Month 12 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2013 Year 03 Month 22 Day
Anticipated trial start date
2013 Year 03 Month 22 Day
Last follow-up date
2013 Year 12 Month 31 Day
Date of closure to data entry
2014 Year 01 Month 31 Day
Date trial data considered complete
2014 Year 02 Month 28 Day
Date analysis concluded
2014 Year 05 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 04 Month 12 Day
Last modified on
2017 Year 04 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012241